Metraipolis › archive › dc_431bd874bd66
Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ… — Europe PMC PMID:41383503
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41383503
- DOI
- 10.3389/fonc.2025.1707876
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:13:30.936Z
- SHA-256 of the archived text
36fee5608a6b1280f5d2e0ded7738ea0bd1bda22620fe4d0bf2db43913515b04- Stable URL of this page
https://metraipolis.com/documento/dc_431bd874bd66
How to cite
Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ… — Europe PMC PMID:41383503 — Europe PMC (en), https://europepmc.org/article/MED/41383503 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_431bd874bd66 (Metraipolis archive dc_431bd874bd66, sha256 36fee5608a6b1280f5d2e0ded7738ea0bd1bda22620fe4d0bf2db43913515b04)
BibTeX
@misc{dc431bd874bd66,
title = {Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ… — Europe PMC PMID:41383503},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41383503},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_431bd874bd66; sha256 36fee5608a6b1280f5d2e0ded7738ea0bd1bda22620fe4d0bf2db43913515b04},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41383503. Agents can read the archived copy with the MCP tool read_document.